Clinical Trials Browser

Phase 1 × Recruiting × Peripheral Nervous System Diseases × Clear all

NCT07484022 2026-05-15

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

Phase 1 Recruiting

Carcinoma, Transitional Cell, Peripheral Nervous System Diseases